Trump Signs Order Expediting Drugs for Mental Health Treatment

President Donald Trump signed an executive order on Saturday directing the FDA to accelerate its review of certain psychedelic drugs that have already been classified as “breakthrough therapy” treatments. The move is intended to speed up access to emerging mental health therapies, particularly for military veterans suffering from PTSD, depression, and traumatic brain injuries.

Trump described the order as a “moment” for medical innovation, saying it would remove bureaucratic delays that have slowed down promising treatments. According to him, many psychedelic therapies are already in advanced clinical trials and have shown significant potential to improve patient outcomes when used under medical supervision.